Through Pfizer Ignite, Acepodia will gain access to Pfizer's resources, scale and expertise as the company broadens the application of its platform beyond oncology into autoimmune diseases Pfizer ...

Because CDCs retain the physiochemical plasticity of drugs and the physiological functions of cells, they can be designed for specific treatment needs and disease contexts 35. When designing CDCs, the ...

Acepodia Inc.’s antibody cell conjugation platform could change the way CAR T-cell therapies are manufactured, clearing the way for an off-the-shelf model to treat numerous cancers that is safer and ...

Leukocytes interact with other cells using cell surface receptors. The largest group of such receptors are non-catalytic tyrosine phosphorylated receptors (NTRs), also called immunoreceptors. NTR ...

The companies will combine their complementary expertise in synthetic oligosaccharides, conjugation process development and GMP vaccine ...